Sleep well, knowing
you’ll have the financial
resources to live well

Performance



Daily Prices

Series Current NAVPS Prior NAVPS NAVPS Change Net Asset Value Last Updated
A $ 0.0000 $ 0.0000 nan% $ 2023-07-24
F $ 0.0000 $ 0.0000 nan% $ 2023-07-24
O $ 0.0000 $ 0.0000 nan% $ 2023-07-24
T8A $ 0.0000 $ 0.0000 nan% $ 2023-07-24
* Closed to new purchases.

Series Rolling Returns (%)

Series 1 Month 3 Month 6 Month Year To Date 1 Year 3 Year 5 Year 10 Year Since Inception Inception Date
A 1.1 0.1 12.2 7.5 2.3 3.5 1.1 3.8 2.4 2008-05-31
F 1.2 0.7 12.7 8.2 3.3 4.6 2.2 4.9 3.5 2008-05-31
T8A 1.1 0.1 12.2 7.4 2.2 3.4 1.1 3.7 2.3 2008-05-31

Calendar Returns

CALENDAR RETURN 20222021202020192018201720162015201420132012
A -29.4% 11.2 22.1 11.4 (9.6) 11.9 (10.4) 17.7 3.3 27.2 15.6
B 10.4 21.4 10.8 (10.2) 11.1 (11.0) 17.1 2.7 26.4 14.9
C 2.8 26.4 14.8
F -29.0% 12.3 23.3 12.7 (8.7) 13.4 (9.5) 18.9 4.4 28.5 16.9
T8A -29.4% 11.0 21.8 11.5 (9.6) 11.7 (10.6) 17.8 3.3 27.1 15.7
T8B 2.9 26.8 15.0
T8C 14.8
L 10.5 21.4 10.8 (10.1) 11.1 (11.0) 17.2 2.8 26.6 15.0
Benchmark -11.9% 17.3 14.6 21.8 (7.4) 16.9 (2.8) 15.7 2.5 33.8 16.6

Growth of $10,000 Since Inception

Portfolio Composition (%)

Top Holdings (%)

HOLDINGS
1 Mastercard Inc. 3.4
2 Visa Inc. 3.3
3 AstraZeneca 3.2
4 L'Oreal 3.2
5 Linde plc 3.0
6 Evoqua Water Technologies Corp. 3.0
7 Thermo Fisher Scientific Inc. 2.9
8 ASML Holding NV 2.8
9 Adobe Inc. 2.7
10 Halma plc 2.6
Total 30.1%

Fund Management Expense Ratio As of December 31, 2021

A B F L T8A
2.85% 3.52% 1.81% 3.47% 3.02%